Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 12.42
(2.14%)
CNY 12.42
(2.14%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 171.36 Million CNY | 52.99% |
| 2022 | 112.01 Million CNY | 28.41% |
| 2021 | 87.22 Million CNY | -40.98% |
| 2020 | 147.8 Million CNY | 105.26% |
| 2019 | 72 Million CNY | 69.84% |
| 2018 | 42.39 Million CNY | -29.87% |
| 2017 | 60.45 Million CNY | -13.85% |
| 2016 | 70.18 Million CNY | 32.84% |
| 2015 | 52.83 Million CNY | -16.96% |
| 2014 | 63.62 Million CNY | -14.13% |
| 2013 | 74.08 Million CNY | -13.32% |
| 2012 | 85.47 Million CNY | 36.28% |
| 2011 | 62.72 Million CNY | 41.98% |
| 2010 | 44.17 Million CNY | 43.05% |
| 2009 | 30.88 Million CNY | 11.43% |
| 2008 | 27.71 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 19.01 Million CNY | 5997.57% |
| 2024 Q1 | 42.96 Million CNY | 33.44% |
| 2024 Q2 | 311.87 Thousand CNY | -99.27% |
| 2023 Q2 | 46.14 Million CNY | -20.27% |
| 2023 Q3 | 35.14 Million CNY | -23.85% |
| 2023 Q4 | 32.19 Million CNY | -8.37% |
| 2023 FY | 171.36 Million CNY | 52.99% |
| 2023 Q1 | 57.88 Million CNY | 172.91% |
| 2022 Q1 | 13.73 Million CNY | -2.63% |
| 2022 Q4 | 21.2 Million CNY | -54.11% |
| 2022 Q2 | 30.85 Million CNY | 124.59% |
| 2022 Q3 | 46.21 Million CNY | 49.8% |
| 2022 FY | 112.01 Million CNY | 28.41% |
| 2021 Q3 | 2.31 Million CNY | -95.15% |
| 2021 Q4 | 14.1 Million CNY | 510.32% |
| 2021 Q1 | 23.14 Million CNY | 137.72% |
| 2021 FY | 87.22 Million CNY | -40.98% |
| 2021 Q2 | 47.66 Million CNY | 105.98% |
| 2020 FY | 147.8 Million CNY | 105.26% |
| 2020 Q3 | 74.4 Million CNY | 63.4% |
| 2020 Q2 | 45.53 Million CNY | 151.12% |
| 2020 Q4 | 9.73 Million CNY | -86.92% |
| 2020 Q1 | 18.13 Million CNY | -24.91% |
| 2019 Q2 | 12.25 Million CNY | 5.45% |
| 2019 Q4 | 24.14 Million CNY | 0.68% |
| 2019 FY | 72 Million CNY | 69.84% |
| 2019 Q1 | 11.62 Million CNY | 313.19% |
| 2019 Q3 | 23.98 Million CNY | 95.69% |
| 2018 Q4 | -5.45 Million CNY | -134.52% |
| 2018 FY | 42.39 Million CNY | -29.87% |
| 2018 Q2 | 13.79 Million CNY | -24.46% |
| 2018 Q1 | 18.26 Million CNY | 9067.58% |
| 2018 Q3 | 15.79 Million CNY | 14.48% |
| 2017 Q3 | 15.44 Million CNY | -12.09% |
| 2017 Q4 | 199.2 Thousand CNY | -98.71% |
| 2017 Q2 | 17.57 Million CNY | -35.5% |
| 2017 FY | 60.45 Million CNY | -13.85% |
| 2017 Q1 | 27.24 Million CNY | 56.18% |
| 2016 FY | 70.18 Million CNY | 32.84% |
| 2016 Q2 | 12.93 Million CNY | -39.48% |
| 2016 Q1 | 21.37 Million CNY | 87.23% |
| 2016 Q3 | 18.43 Million CNY | 42.53% |
| 2016 Q4 | 17.44 Million CNY | -5.39% |
| 2015 Q2 | 11.99 Million CNY | -38.93% |
| 2015 FY | 52.83 Million CNY | -16.96% |
| 2015 Q4 | 11.41 Million CNY | 16.69% |
| 2015 Q1 | 19.64 Million CNY | 44.43% |
| 2015 Q3 | 9.78 Million CNY | -18.45% |
| 2014 Q4 | 13.6 Million CNY | 9.53% |
| 2014 Q2 | 16.57 Million CNY | -21.18% |
| 2014 Q1 | 21.02 Million CNY | 6.95% |
| 2014 FY | 63.62 Million CNY | -14.13% |
| 2014 Q3 | 12.41 Million CNY | -25.09% |
| 2013 Q3 | 11 Million CNY | -34.73% |
| 2013 Q1 | 26.56 Million CNY | 19.67% |
| 2013 FY | 74.08 Million CNY | -13.32% |
| 2013 Q4 | 19.66 Million CNY | 78.71% |
| 2013 Q2 | 16.85 Million CNY | -36.56% |
| 2012 FY | 85.47 Million CNY | 36.28% |
| 2012 Q4 | 22.2 Million CNY | -0.94% |
| 2012 Q3 | 22.41 Million CNY | 32.58% |
| 2012 Q2 | 16.9 Million CNY | -29.43% |
| 2012 Q1 | 23.95 Million CNY | 8.89% |
| 2011 Q1 | 12.93 Million CNY | 0.0% |
| 2011 FY | 62.72 Million CNY | 41.98% |
| 2011 Q2 | 11.13 Million CNY | -13.96% |
| 2011 Q3 | 16.65 Million CNY | 49.62% |
| 2011 Q4 | 21.99 Million CNY | 32.08% |
| 2010 FY | 44.17 Million CNY | 43.05% |
| 2009 FY | 30.88 Million CNY | 11.43% |
| 2008 FY | 27.71 Million CNY | 0.0% |